News
Welcome to our new colleagues!
We are happy to welcome Lisa, Lucien, Julia G., Julia L. and Natasja who joined Lygature in the fall of 2021! You can meet them below and find out more about their background, expertise and responsibilities within our team in Lygature.
Lisa Scheefhals holds a Master’s degree in Biomedical Sciences, followed by a Minor in Science and Business Management. Lygature perfectly matches her ambition to connect and bundle the strengths of public and private partners to truly make a difference in the (bio)medical field.
Throughout her professional career, Lisa gained experience in both research and business, from an academic, consultancy, and funder perspective. The time at life sciences and business consultancy company ttopstart further sparked her interest in supporting large multi-stakeholder and interdisciplinary partnerships. At health research funding organization ZonMw she could further build upon this passion, while working on the international Joint Programming Initiative on Antimicrobial Resistance engaging 28 nations and the European Commission to curb antimicrobial resistance, and projects related to Open Science.
Lisa joined Lygature as Program Manager and will be working on the partnerships Health Innovation Netherlands (HI-NL) and Health-RI.
Lucien de Brabander holds a bachelor’s degree in Business Administration / Business economics. And a master’s degree in Sociology (Labor, Organization and Management), during his studies he finished additional mathematics courses.
His professional background clearly shows his passion for Finance work. Throughout his career, Lucien worked on 4 different Finance positions for Unilever and BP. At a later stage he did gain experience somewhat out of the Finance realm as well, as Project Manager; he worked as a Digital Marketing Project Manager, Digital Execution Manager a.i. and eventually B2B2C Product Manager a.i. for BP for the last 3 years. Despite the fact he enjoyed this last part of the journey, he decided to specialize in Finance / Controlling in the foreseeable future.
By combining all his experience, he is always aiming for sharing his Finance, organizational process and project management insights with others. Driven by a set of characteristics which can be qualified easy going, multidisciplinary, curious and lean. Within Lygature he will focus on the Data Infrastructure portfolio.
Julia Gencheva joined as a Program Operations Manager at Lygature, where she is responsible for developing, implementing, and optimising the structure and processes of our projects. She has operational involvement in PERSIST-SEQ and the Pediatric Praziquantel Consortium. Additionally, she is supporting the closing of APPROACH and RADAR-CNS projects.
Julia holds a MSc in Public Management and Leadership from Leiden University, The Netherlands. She has acquired experience in coordination and management of multi-stakeholder innovations initiatives while working as a project coordinator for the United Nations for three years before joining Lygature.
Julia Lischke has a scientific background in technical biology and system dynamics. As a PhD student at the Institute of System Dynamics at the University of Stuttgart, she worked in the field of personalised medicine on the prediction of severe side effects in chemotherapy. Most recently, she worked as a postdoctoral researcher at the Vrije Universiteit Amsterdam on the development of predictive models for microbial communities. During this time, she acquired experience in project management in the Horizon 2020 project YogurtDesign.
Julia joined Lygature as a Program Manager and she will be working on the programs Health-RI and BY-Covid.
Natasja Franceschini is a Program Manager at Lygature, where she is responsible for the management of private-public partnerships funded by IMI.
Natasja holds a master’s degree in Molecular Medicine from the Erasmus University in Rotterdam. She continued her studies as a PhD-student at the Leiden University Medical Center. During this PhD program she focussed on the identification of novel targets and treatment options for rare bone tumours.
Within Lygature, she has joined the program management of European Lead Factory and PERSIST-SEQ.